OncoVista, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.oncovista.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Phase 1
- Conditions
- Refractory TdT-Positive Leukemia
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2009-01-09
- Lead Sponsor
- OncoVista, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT00709215
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Cancer Therapy Reasearch Center at UTHSCA, San Antonio, Texas, United States
News
No news found